共 19 条
[1]
METHOTREXATE IN RHEUMATOID-ARTHRITIS - TOXIC EFFECTS AS THE MAJOR FACTOR IN LIMITING LONG-TERM TREATMENT
[J].
ARTHRITIS AND RHEUMATISM,
1989, 32 (06)
:671-676
[3]
GOLDEN M R, 1990, Arthritis and Rheumatism, V33, pS40
[4]
HANRAHAN PS, 1989, BRIT J RHEUMATOL, V28, P147
[5]
LONG-TERM PROSPECTIVE-STUDY OF THE USE OF METHOTREXATE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - UPDATE AFTER A MEAN OF 90 MONTHS
[J].
ARTHRITIS AND RHEUMATISM,
1992, 35 (02)
:138-145
[7]
ANALYSIS OF IMPROVEMENT IN INDIVIDUAL RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BASED ON THE FINDINGS IN PATIENTS TREATED WITH PLACEBO
[J].
ARTHRITIS AND RHEUMATISM,
1990, 33 (04)
:477-484
[8]
PRELIMINARY CRITERIA FOR CLINICAL REMISSION IN RHEUMATOID-ARTHRITIS
[J].
ARTHRITIS AND RHEUMATISM,
1981, 24 (10)
:1308-1315
[9]
ASSESSMENT OF PATIENT SATISFACTION IN ACTIVITIES OF DAILY LIVING USING A MODIFIED STANFORD HEALTH ASSESSMENT QUESTIONNAIRE
[J].
ARTHRITIS AND RHEUMATISM,
1983, 26 (11)
:1346-1353
[10]
PINCUS T, 1992, J RHEUMATOL, V19, P1885